|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
| Phenotypic Information (metabolism pathway, cancer, disease, phenome) |
| |
| |
| Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG |
| |
|
| Gene Summary for AGPAT3 |
| Basic gene info. | Gene symbol | AGPAT3 |
| Gene name | 1-acylglycerol-3-phosphate O-acyltransferase 3 | |
| Synonyms | LPAAT-GAMMA1|LPAAT3 | |
| Cytomap | UCSC genome browser: 21q22.3 | |
| Genomic location | chr21 :45345278-45407475 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001037553.1, NM_020132.4, | |
| Ensembl id | ENSG00000160216 | |
| Description | 1-AGP acyltransferase 31-AGPAT 31-acyl-sn-glycerol-3-phosphate acyltransferase gammalysophosphatidic acid acyltransferase gammalysophosphatidic acid acyltransferase-gamma1 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 614794 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000160216 | ||
| HPRD : 10637 | ||
| Vega : OTTHUMG00000086892 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_AGPAT3 | |
| BioGPS: 56894 | ||
| Gene Expression Atlas: ENSG00000160216 | ||
| The Human Protein Atlas: ENSG00000160216 | ||
| Pathway | NCI Pathway Interaction Database: AGPAT3 | |
| KEGG: AGPAT3 | ||
| REACTOME: AGPAT3 | ||
| ConsensusPathDB | ||
| Pathway Commons: AGPAT3 | ||
| Metabolism | MetaCyc: AGPAT3 | |
| HUMANCyc: AGPAT3 | ||
| Regulation | Ensembl's Regulation: ENSG00000160216 | |
| miRBase: chr21 :45,345,278-45,407,475 | ||
| TargetScan: NM_001037553 | ||
| cisRED: ENSG00000160216 | ||
| Context | iHOP: AGPAT3 | |
| cancer metabolism search in PubMed: AGPAT3 | ||
| UCL Cancer Institute: AGPAT3 | ||
| Assigned class in ccmGDB | C | |
| Top |
| Phenotypic Information for AGPAT3(metabolism pathway, cancer, disease, phenome) |
| Cancer | CGAP: AGPAT3 |
| Familial Cancer Database: AGPAT3 | |
| * This gene is included in those cancer gene databases. |
|
|
|
|
|
| . | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
| KEGG_GLYCEROLIPID_METABOLISM KEGG_GLYCEROPHOSPHOLIPID_METABOLISM REACTOME_PHOSPHOLIPID_METABOLISM REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS | |
| OMIM | |
| Orphanet | |
| Disease | KEGG Disease: AGPAT3 |
| MedGen: AGPAT3 (Human Medical Genetics with Condition) | |
| ClinVar: AGPAT3 | |
| Phenotype | MGI: AGPAT3 (International Mouse Phenotyping Consortium) |
| PhenomicDB: AGPAT3 | |
| Mutations for AGPAT3 |
| * Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
| - Statistics for Tissue and Mutation type | Top |
![]() |
| - For Inter-chromosomal Variations |
| * Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
![]() |
| - For Intra-chromosomal Variations |
| * Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
![]() |
| Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
| ovary | AGPAT3 | chr21 | 45376064 | 45376084 | AGPAT3 | chr21 | 45384107 | 45384127 |
| pancreas | AGPAT3 | chr21 | 45348999 | 45349019 | RUNX1 | chr21 | 36167152 | 36167172 |
| cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
| * From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows AGPAT3 related fusion information. |
| ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
| BF955600 | TMOD1 | 2 | 79 | 9 | 100353599 | 100353676 | AGPAT3 | 75 | 141 | 21 | 45302061 | 45302127 | |
| AK125812 | AGPAT3 | 1 | 78 | 21 | 45366864 | 45366941 | ATP1A4 | 76 | 3797 | 1 | 160136317 | 160156576 | |
| DB062417 | AGPAT3 | 1 | 78 | 21 | 45366864 | 45366941 | ATP1A4 | 76 | 538 | 1 | 160136317 | 160137220 | |
| BF955597 | TMOD1 | 1 | 90 | 9 | 100353587 | 100353676 | AGPAT3 | 86 | 152 | 21 | 45302061 | 45302127 | |
| Top |
| Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
| Total # sample | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
| GAIN (# sample) | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
| LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
| Top |
|
![]() |
| Top |
| Stat. for Non-Synonymous SNVs (# total SNVs=25) | (# total SNVs=12) |
![]() | ![]() |
(# total SNVs=0) | (# total SNVs=0) |
| Top |
| * When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
| GRCh37 position | Mutation(aa) | Unique sampleID count |
| chr21:45402199-45402199 | p.R353C | 5 |
| chr21:45379734-45379734 | p.W58R | 2 |
| chr21:45379739-45379739 | p.S59S | 2 |
| chr21:45379596-45379596 | p.V12M | 2 |
| chr21:45401010-45401010 | p.G328G | 2 |
| chr21:45390643-45390643 | p.R207Q | 1 |
| chr21:45400872-45400872 | p.D282D | 1 |
| chr21:45389131-45389131 | p.R161C | 1 |
| chr21:45402243-45402243 | p.Y367Y | 1 |
| chr21:45391304-45391304 | p.G234R | 1 |
| Top |
|
![]() |
| Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| # sample | 2 | 2 |   | 8 |   |   | 1 |   |   |   |   | 2 | 2 | 1 | 1 | 1 | 6 | 3 |   | 5 |
| # mutation | 2 | 2 |   | 8 |   |   | 1 |   |   |   |   | 2 | 2 | 1 | 1 | 1 | 7 | 3 |   | 6 |
| nonsynonymous SNV | 2 | 2 |   | 4 |   |   | 1 |   |   |   |   | 2 | 1 | 1 | 1 | 1 | 6 | 2 |   | 4 |
| synonymous SNV |   |   |   | 4 |   |   |   |   |   |   |   |   | 1 |   |   |   | 1 | 1 |   | 2 |
| cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
| Top |
| * We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
| Genomic Position | Mutation(aa) | Unique sampleID count |
| chr21:45402199 | p.R353C,AGPAT3 | 3 |
| chr21:45387862 | p.G328G,AGPAT3 | 2 |
| chr21:45401010 | p.E72Q,AGPAT3 | 2 |
| chr21:45400968 | p.T154N,AGPAT3 | 1 |
| chr21:45387860 | p.P295S,AGPAT3 | 1 |
| chr21:45391304 | p.R161H,AGPAT3 | 1 |
| chr21:45400973 | p.W314C,AGPAT3 | 1 |
| chr21:45391317 | p.R161R,AGPAT3 | 1 |
| chr21:45400990 | p.T316N,AGPAT3 | 1 |
| chr21:45389009 | p.T178M,AGPAT3 | 1 |
| * Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
| cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
| Top |
| Gene Expression for AGPAT3 |
| * CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
| * Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
| Top |
| * This plots show the correlation between CNV and gene expression. |
![]() |
|
![]() |
|
| Top |
| Gene-Gene Network Information |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() |
|
| AGPAT3,BRWD1,DOPEY2,DSCR3,DYRK1A,HLCS,LSS, NDUFV3,PCNT,PFKL,PWP2,RRP1B,SLC19A1,SLC37A1, SUMO3,TRAPPC10,TTC3,UBE2G2,URB1,WRB,ZBTB7B | ABCB6,AGPAT3,AIFM1,ALDH4A1,GUCD1,CRAT,CUX1, DKFZp779M0652,FITM2,GPI,HECTD3,ICMT,IGF2R,ITFG3, NPLOC4,PREB,PSMD2,SUOX,TRIM16L,VCP,ZFAND3 |
![]() |
|
| AGPAT3,C2CD2,CGN,DIP2A,DSCR3,DYRK1A,HLCS, LSS,MCM3AP,MYO18A,PCNT,PDXK,PFKL,PITPNM1, HELZ2,PWP2,RIPK4,RRP1B,TRAPPC10,UBE2G2,URB1 | AGPAT3,ATG9A,C1orf115,ESPN,GDPD2,GNA11,HECA, HECTD3,KIAA0247,KIF3B,LASP1,LOC151534,MAST2,MYO7B, PDXK,PIGS,POR,RXRA,SLC9A3R1,SPINT1,TGOLN2 |
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
| Top |
| Top |
| Pharmacological Information for AGPAT3 |
| There's no related Drug. |
| Top |
| Cross referenced IDs for AGPAT3 |
| * We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
|
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |